Claudio N. Cavasotto

Author

The University of Texas Health Science Center at Houston ORCID

Also Known As

C N Cavasotto, C. Cavasotto, C. N. Cavasotto, C.N Cavasotto, C.N. Cavasotto, Cavasotto, C.N., Claudio Cavasotto, Claudio N Cavasotto, Claudio N. Cavasotto, Claudio N. Cavasotto

109

Publications

5.5K

Citations

H-Index

128

Concepts

All Affiliations

The University of Texas Health Science Center at Houston Consejo Nacional de Investigaciones Científicas y Técnicas Austral University Biomedicine Research Institute of Buenos Aires - CONICET - Partner Institute of the Max Planck Society Scripps Research Institute

About

Claudio N. Cavasotto is an author at The University of Texas Health Science Center at Houston specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	32	2.5K
2	Natural Sciences	20	24	1.8K
3	Engineering	13	15	730
4	Biochemistry	10	10	656
5	Applied Physics	2	2	61

Claudio N. Cavasotto

Publications

Citations

H-Index

Page 1

	Year	Citations
Protein Flexibility in Ligand Docking and Virtual Screening to Protein Kinases Claudio N. Cavasotto, Ruben Abagyan Journal of Molecular Biology Virtual ScreeningProtein FlexibilityProtein AssemblyProtein FoldingNatural Sciences	2004	413
Representing Receptor Flexibility in Ligand Docking through Relevant Normal Modes Claudio N. Cavasotto, Julio Kovacs, Ruben Abagyan Journal of the American Chemical Society EngineeringMolecular BiologyProtein FoldingMolecular RecognitionBiophysics	2005	286
Glucocorticoid Receptor Phosphorylation Differentially Affects Target Gene Expression Weiwei Chen, Thoa Dang, Raymond D. Blind, Molecular Endocrinology Molecular BiologyGlucocorticoidGlucocorticoid ReceptorCellular PhysiologyTranscriptional Regulation	2008	274
Exponential consensus ranking improves the outcome in docking and receptor ensemble docking Karen Palacio‐Rodríguez, Isaías Lans, Claudio N. Cavasotto, Scientific Reports	2019	176
How good are AlphaFold models for docking-based virtual screening? Valeria Scardino, Juan I. Di Filippo, Claudio N. Cavasotto iScience	2022	172
Discovery of Novel Chemotypes to a G-Protein-Coupled Receptor through Ligand-Steered Homology Modeling and Structure-Based Virtual Screening Claudio N. Cavasotto, Andrew Orry, Nicholas Murgolo, Journal of Medicinal Chemistry Drug TargetG-protein-coupled ReceptorMolecular BiologyNovel ChemotypesMedicinal Chemistry	2008	169
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy Mario Rossi, Barak Rotblat, Keith H. Ansell, Cell Death and Disease	2014	129
Ligand and Decoy Sets for Docking to G Protein-Coupled Receptors Edgar A. Gatica, Claudio N. Cavasotto Journal of Chemical Information and Modeling Molecular RecognitionSignal TransductionDecoy SetsBiochemistryGpcr Decoy Database	2011	107
<i>In silico</i> Drug Repurposing for COVID‐19: Targeting SARS‐CoV‐2 Proteins through Docking and Consensus Ranking Claudio N. Cavasotto, Juan I. Di Filippo Molecular Informatics Quantum Mechanical ScoringMedicineImmunologyPharmacologyRational Drug Design	2020	105
High-throughput and<i>in silico</i>screenings in drug discovery Sharangdhar S. Phatak, Clifford Stephan, Claudio N. Cavasotto Expert Opinion on Drug Discovery	2009	95

Page 1